Ligand · JVE
JVE · (4S)-4-(2-fluorophenyl)-2,4,6,7,8,9-hexahydro-5H-pyrazolo[3,4-b][1,7]naphthyridin-5-one
JVE, (4S)-4-(2-fluorophenyl)-2,4,6,7,8,9-hexahydro-5H-pyrazolo[3,4-b][1,7]naphthyridin-5-one (C15 H13 F N4 O, 284.3 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues…
- Component
- JVE
- Formula
- C15 H13 F N4 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
JVE in 2 structures; the first of them:
- 4UZH · SAR156497 an exquisitely selective inhibitor of Aurora kinases · JVE A1392 · binds LEU139, GLY140, VAL147, ALA160, LYS162, LEU194, LEU210, GLU211 and 6 more
- 4UZH · SAR156497 an exquisitely selective inhibitor of aurora kinases · JVE A1392 · binds LEU139, GLY140, VAL147, ALA160, LYS162, LEU194, LEU210, GLU211 and 6 more
Residues it binds most
LEU 2, ALA 2, GLU 2, GLY 2, LYS 2, PHE 2, THR 2, TYR 2, VAL 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.